ProBioGen AG
Dr. Patrick Wefing is currently serving as Project Lead CMC at ProBioGen AG since October 2022. Prior to this role, Dr. Wefing worked as an employee at DWI - Leibniz-Institut für Interaktive Materialien, focusing on research. From April 2017 to October 2022, Dr. Wefing held the position of Wissenschaftlicher Mitarbeiter at ILT.NRW - Institut für Lebensmitteltechnologie Nordrhein-Westfalen and was previously a Wissenschaftlicher Mitarbeiter mit akademischem Abschluss at Universität Bayreuth from August 2016 to March 2017. Dr. Wefing is pursuing a doctorate in Biotechnology at Technische Universität Berlin, having completed a Master’s degree in Molecular and Applied Biotechnology at RWTH Aachen University, and a Bachelor's degree in Biotechnology at Hochschule Ostwestfalen-Lippe.
This person is not in the org chart
ProBioGen AG
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.